GENETIC ASSOCIATION OF KCNJ11 POLYMORPHISM AND TYPE 2 DIABETES SUSCEPTIBILITY: A CASE-CONTROL APPROACH

Authors

  • Shubhangi Chaturvedi Department of Biotechnology, School of Life-Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raibareli Road, Lucknow – 226 025, Uttar Pradesh (India)
  • Pooja Department of Biotechnology, School of Life-Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raibareli Road, Lucknow – 226 025, Uttar Pradesh (India)
  • Shivangi Singh Department of Biotechnology, School of Life-Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raibareli Road, Lucknow – 226 025, Uttar Pradesh (India)
  • Shefali Singh M.D. Medicine, Physician, Dr. O.P. Chaudhary Hospital and Research Center, Raibareli Rd, Sector 1, Chaudhary Vihar, Lucknow – 226 025, Uttar Pradesh (India)
  • Tridiv Katiyar Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow – 226 025, Uttar Pradesh (India)
  • Dinesh Raj Modi Department of Biotechnology, School of Life-Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raibareli Road, Lucknow – 226 025, Uttar Pradesh (India)

DOI:

https://doi.org/10.48165/abr.2025.27.01.1

Keywords:

Antidiabetic drugs, Genetic variation, KCNJ11, polymorphism, type 2 diabetes mellitus

Abstract

Diabetes is globally one of the leading non-communicable diseases that pose significant public health challenges. The Potassium Inwardly Rectifying Channel Subfamily J Member 11 (KCNJ11) gene polymorphism has been implicated in beta-cell dysfunction and altered insulin secretion through potassium-gated channels, potentially influencing type 2 diabetes mellitus (T2DM) susceptibility. Genotyping was performed using restriction fragment length polymorphism, with verification through Sanger Sequencing. The association between KCNJ11 genotypes and T2DM risk was evaluated using odds ratios and confidence intervals. Biochemical and clinical variables were compared between patients and controls using Student’s t-test and Chi-square (χ²) tests. Statistical analysis was conducted using SPSS software. The frequency distribution of KCNJ11 (rs5210) SNP (A/G) differed significantly between the control group and T2DM patients (X² = 31.7). The dominant genetic model (p value <0.00; OR = 4.41) showed its strong association with T2DM. Drug response analysis highlighted those patients with the GG genotype responded better to metformin + sulfonylurea (M + S) compared to lantus + gliptin (L + G), indicating genotype-specific therapeutic efficacy. This study confirms that the rs5210 genetic variant of KCNJ11 gene significantly increases susceptibility to T2DM. Furthermore, the GG genotype may influence the effectiveness of antidiabetic therapies, providing a potential basis for personalized treatment strategies. These findings underscore the importance of genetic screening in diabetes management.

Downloads

Download data is not yet available.

References

Aida, N., Maliza, R., Faridah, I.N., Widianingrum, M. and Perwitasari, D.A. 2020. Identification SNP rs5219 KCNJ11 gene and blood glucose levels in type 2 diabetes mellitus patients at Moewardi Hospital Surakarta. Pharmaciana, 11: 347-354.

Aka, T.D., Saha, U., Shati, S.A., Aziz, M.A., Begum, M. and Hussain, M.S. 2021. Risk of type 2 diabetes mellitus and cardiovascular complications in KCNJ11, HHEX and SLC30A8 genetic polymorphisms carriers: A case-control study. Heliyon, 7: e08376 [10.1016/j.heliyon.2021.e08376].

Alshammary, A.F., Al-Hakeem, M.M. and Ali Khan, I. 2023. Saudi community-based screening study on genetic variants in β-cell dysfunction and its role in women with gestational diabetes mellitus. Genes, 4: 924. [https://doi.org/10.3390/genes14040924].

Alqadri, N. 2022. Independent case-control study in KCNJ11 gene polymorphism with type 2 diabetes mellitus. Saudi Journal of Biological Sciences, 4: 2794-2799.

Aswathi, R., Viji, D., Charmine, P.S.P., Husain, R.S.R.A., Ameen, S.H.N., Ahmed, S.S. and Ramakrishnan, V. 2020. Influence of KCNJ11 gene polymorphism in T2DM of south Indian population. Frontiers in Bioscience-Elite, 12: 199-222.

Bhargave, A., Ahmad, I., Yadav, A. and Gupta, R. 2023. Correlating the role of KCNJ11 polymorphism (rs5219) and T2DM: A case control study. International Journal of Diabetes in Developing Countries, 44: 175-181.

Čejková, P., Novota, P., Černá, M., Kološtová, K., Nováková, D. and Kučera, E. 2007. KCNJ11 E23K polymorphism and diabetes mellitus with adult onset in Czech patients. Folia Biologica (Praha), 53: 173-175.

Chistiakov, D.A., Potapov, V.A., Khodirev, D.C., Shamkhalova, M.S. and Shestakova, M.V. 2009. Genetic variations in the pancreatic ATP-sensitive potassium channel, β-cell dysfunction, and susceptibility to type 2 diabetes. Acta Diabetologica, 46: 43-49.

10 Shubhangi Chaturvedi et al.

Chiu, T.H., Pan, W.H., Lin, M.N. and Lin, C.L. 2018. Vegetarian diet, change in dietary patterns, and diabetes risk: A prospective study. Nutrition & Diabetes, 8: 12. [https://doi.org/10.1038/s41387-018-0022-4].

Cruz, M., Valladares-Salgado, A., Garcia-Mena, J., Ross, K., Edwards, M. and Angeles-Martinez, J. 2010. Candidate gene association study conditioning on individual ancestry in patients with type 2 diabetes and metabolic syndrome from Mexico city. Diabetes/Metabolism Research and Reviews, 26: 261-270.

Engwa, G.A., Nwalo, F.N., Obi, C.E., Onyia, C., Ojo, O. and Mbacham, W. 2018. Predominance of an allele but no association of the KCNJ11 rs5219 E23K polymorphism with type 2 diabetes in a Nigerian population. Genetics and Molecular Research, 17: gmr160039889 [10.4238/gmr16039889].

Gong, B., Yu, J., Li, H., Li, W. and Tong, X. 2012. The effect of KCNJ11 polymorphism on the risk of type 2 diabetes: A global meta-analysis based on 49 case-control studies. DNA and Cell Biology. 31: 801-810. [https://doi.org/10.1089/dna.2011.1445].

Haghvirdizadeh P., Mohamed Z., Abdullah N.A., Haghvirdizadeh P., Haerian M.S. and Haerian B.S. 2015. KCNJ11: Genetic polymorphisms and risk of diabetes mellitus. Journal of Diabetes Research, 2015: 908152 [https://doi.org/10.1155/2015/908152].

Hansen, S.K., Nielsen, E.M.D., Ek, J., Andersen, G., Glümer, C. and Carstensen, B. 2005. Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism, 90: 3629-3637.

Isakova, J., Talaibekova, E., Vinnikov, D., Saadanov, I. and Aldasheva, N. 2019. ADIPOQ, KCNJ 11 and TCF 7L2 polymorphisms in type 2 diabetes in Kyrgyz population: A case-control study. Journal of Cellular and Molecular Medicine, 23: 1628-1631.

Jamil, K., Asimuddin, M., Alqahtani, M.S., Alshehri, M., Mateen, A., Aduderman, A.W.A. and Malik, A. 2020. Molecular and biochemical analysis of Pro12Ala variant of PPAR-γ2 gene in type 2 diabetes mellitus. Saudi Journal of Biological Sciences, 9: 2439-2443.

Khan, I.A., Vattam, K.K., Jahan, P., Mukkavali, K.K., Hasan, Q. and Rao, P. 2015. Correlation between KCNQ1 and KCNJ11 gene polymorphisms and type 2 and post-transplant diabetes mellitus in the Asian Indian population. Genes Diseases, 2: 276-282.

Khan, V., Bhatt, D., Khan, S., Verma, A.K., Hasan, R. and Rafat, S. 2019. Association of KCNJ11 genetic variations with risk of Type 2 diabetes mellitus (T2DM) in North Indian population. Endocrinology and Metabolism, Preprint [https://doi.org/10.20944/preprints201907.0089.v1].

Khan, V., Verma, A.K., Bhatt, D., Khan, S., Hasan, R. and Goyal, Y. 2020. Association of genetic variants of KCNJ11 and KCNQ1 genes with risk of type 2 diabetes mellitus (T2DM) in the Indian population: A case-control study. International Journal of Endocrinology, 2020: 5924756 [https://doi.org/10.1155/2020/5924756].

Koo, B.K., Cho, Y.M., Park, B.L., Cheong, H.S., Shin, H.D. and Jang, H.C. 2007. Polymorphisms of KCNJ11 (Kir6. 2 gene) are associated with type 2 diabetes and hypertension in the Korean population. Diabetic Medicine, 24: 178-186.

Kostov, K. and Blazhev, A. 2020. Use of glycated hemoglobin (A1c) as a biomarker for vascular risk in type 2 diabetes: Its relationship with matrix metalloproteinases-2, -9 and the metabolism of collagen IV and elastin. Medicina, 56: 231 [https://doi.org/10.3390/medicina56050231].

Lee, P.Y., Costumbrado, J., Hsu, C.Y. and Kim, Y.H. 2012. Agarose gel electrophoresis for the separation of DNA fragments. Journal of Visualized Experiments, 62: 3923. [doi: 10.3791/3923]. Liu, L., Kazuaki, N., Takao, Y., Yanjun, L., Hai-rong, H. and Guang, H. 2013. Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetes. Diabetologia, 56: 2609-2618.

Makhzoom, O., Kabalan, Y. and Al-Quobaili, F. 2019. Association of KCNJ11 rs5219 gene polymorphism with type 2 diabetes mellitus in a population of Syria: A case-control study. BMC Medical Genetics, 20: 1-6. [https://doi.org/10.1186/s12881-019-0846-3].

Muftin, N.Q. and Jubair, S. 2019. KCNJ11 polymorphism is associated with type 2 diabetes mellitus in Iraqi patients. Gene Reports, 17: 100480. [https://doi.org/10.1016/j.genrep.2019.100480]. Muhammad, A.A. and Agussalim, A. 2018. Polymorphism genes sulfonylurea receptor-1 and

potassium inwardly-rectifying channel subfamily J member 11 as a risk factor for type 2 diabetes mellitus in ethnic of ternate. Anatomy and Physiology: Current Research, 8: 2161-0940. Moazzam-Jazi, M., Najd–Hassan-Bonab, L., Masjoudi, S., Tohidi, M., Hedayati, M. and Azizi, F. 2022. Risk of type 2 diabetes and KCNJ11 gene polymorphisms: A nested case–control study and meta-analysis. Scientific Reports, 12: 20709. [https://doi.org/10.1038/s41598-022-24931-x]. Odgerel, Z., Lee, H.S., Erdenebileg, N., Gandbold, S., Luvsanjamba, M., Sambuughin, N. and Goldfarb, L.G. 2012. Genetic variants in potassium channels are associated with type 2 diabetes in a Mongolian population. Journal of Diabetes, 4: 238-242.

Phani, N.M., Guddattu, V., Bellampalli, R., Seenappa, V., Adhikari, P., Nagri, S.K. and Rai, P.S. 2014. Population specific impact of genetic variants in KCNJ11 gene to type 2 diabetes: A case control and meta-analysis study. PLoS One, 9: e107021 [https://doi.org/10.1371/journal.pone.0107021].

Published

2025-03-31

How to Cite

GENETIC ASSOCIATION OF KCNJ11 POLYMORPHISM AND TYPE 2 DIABETES SUSCEPTIBILITY: A CASE-CONTROL APPROACH. (2025). Applied Biological Research, 27(1), 1–11. https://doi.org/10.48165/abr.2025.27.01.1